NASDAQ:CYPH Cypherpunk Technologies (CYPH) Stock Price, News & Analysis $1.19 +0.12 (+11.21%) As of 11:28 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cypherpunk Technologies Stock (NASDAQ:CYPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYPH alerts:Sign Up Key Stats Today's Range$1.08▼$1.2650-Day Range$0.51▼$1.0752-Week Range$0.23▼$3.70Volume12.20 million shsAverage Volume2.73 million shsMarket Capitalization$116.24 millionP/E Ratio17.00Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion. DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies. In addition to DKN-01, Cypherpunk is advancing preclinical programs that target novel pathways involved in cancer cell signaling and immune regulation, with the aim of identifying complementary assets for future clinical development. Founded in 2016 and headquartered in Irvine, California, Leap Therapeutics completed its initial public offering in 2019 and now trades on the NASDAQ under the ticker CYPH. The company conducts clinical trials in the United States and collaborates with academic and industry partners to accelerate its development programs. Michael Stoll, M.D., serves as President and Chief Executive Officer, overseeing a team of experienced professionals in oncology drug discovery and development. AI Generated. May Contain Errors. Read More Cypherpunk Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreCYPH MarketRank™: Cypherpunk Technologies scored higher than 17% of companies evaluated by MarketBeat, and ranked 790th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingCypherpunk Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCypherpunk Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Cypherpunk Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cypherpunk Technologies is 16.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.31.Price to Earnings Ratio vs. SectorThe P/E ratio of Cypherpunk Technologies is 16.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.11.Price to Book Value per Share RatioCypherpunk Technologies has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cypherpunk Technologies' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CYPH. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCypherpunk Technologies does not currently pay a dividend.Dividend GrowthCypherpunk Technologies does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentCypherpunk Technologies has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cypherpunk Technologies this week, compared to 2 articles on an average week.Search Interest4 people have searched for CYPH on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cypherpunk Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders4.30% of the stock of Cypherpunk Technologies is held by insiders.Percentage Held by Institutions30.46% of the stock of Cypherpunk Technologies is held by institutions.Read more about Cypherpunk Technologies' insider trading history. Receive CYPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cypherpunk Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYPH Stock News HeadlinesCypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 | prnewswire.comCypherpunk Technologies Announces Planned Board Leadership TransitionsApril 12, 2026 | theglobeandmail.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 6 at 1:00 AM | Brownstone Research (Ad)Cypherpunk Technologies (NASDAQ:CYPH) Stock, Option ChainApril 10, 2026 | benzinga.comCypherpunk Technologies Rocked by Major Insider Stock SaleMarch 30, 2026 | tipranks.comCypherpunk Reports Full Year 2025 Financial ResultsMarch 16, 2026 | prnewswire.comMajor VCs Back Zcash Developers With $25 Million After ECC SplitMarch 10, 2026 | bitcoinist.comZcash devs raise $25M from major VCs months after ECC splitMarch 9, 2026 | cointelegraph.comSee More Headlines CYPH Stock Analysis - Frequently Asked Questions How have CYPH shares performed this year? Cypherpunk Technologies' stock was trading at $1.16 on January 1st, 2026. Since then, CYPH shares have decreased by 1.2% and is now trading at $1.1466. How were Cypherpunk Technologies' earnings last quarter? Cypherpunk Technologies (NASDAQ:CYPH) issued its quarterly earnings data on Wednesday, November, 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.16. The business earned $0.21 million during the quarter. When did Cypherpunk Technologies' stock split? Cypherpunk Technologies's stock reverse split before market open on Wednesday, June 21st 2023.The 1-10 reverse split was announced on Wednesday, June 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Cypherpunk Technologies? Shares of CYPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/12/2025Today5/06/2026Next Earnings (Estimated)5/18/2026AGM 20266/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 CYPH's financial health is in the Yellow zone, according to TradeSmith. CYPH has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CYPH Previous SymbolNASDAQ:LPTX CIK1509745 Webwww.leaptx.com Phone(617) 714-0360FaxN/AEmployees40Year Founded2011Profitability EPS (Trailing Twelve Months)$0.07 Trailing P/E Ratio16.38 Forward P/E RatioN/A P/E GrowthN/ANet Income$4.82 million Net MarginsN/A Pretax MarginN/A Return on Equity-99.76% Return on Assets-79.44% Debt Debt-to-Equity RatioN/A Current Ratio35.56 Quick Ratio35.56 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book0.63Miscellaneous Outstanding Shares97,680,000Free Float86,111,000Market Cap$112.00 million OptionableOptionable Beta-0.09 Social Links 10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:CYPH) was last updated on 5/6/2026 by MarketBeat.com Staff. From Our PartnersA U.S. Resource Gap Is a National Issue - and OpportunityAmerica still does not domestically produce one mineral tied to batteries, energy storage, and national defens...i2i Marketing Group, LLC | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredTrump and Elon are BACK15X Bigger Than SpaceX: Elon's New Launch While the rest of the market goes crazy for "the mother of all IP...InvestorPlace | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredWhere the SpaceX "Tidal Wave" hits firstThe SpaceX and xAI IPO could trigger one of the largest capital shifts in market history — $1.75 trillion movi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cypherpunk Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share Cypherpunk Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
